Tania Gonsalves

Tania Gonsalves is a highly educated and experienced professional with a background in molecular biology and a successful career in finance. She studied High Honours Bachelor of Science (BSc), Molecular Biology, Specialist at the prestigious University of Toronto. Gonsalves is currently Vice President Equity Research at Canaccord Genuity- Global Capital Markets, where she is responsible for analyzing and evaluating global healthcare and biotech companies. Prior to this, she worked as an Equity Research Analyst at Cormark Securities, specializing in the healthcare sector, as well as an Equity Research Associate and an Institutional Equity Sales representative. Gonsalves has also worked as an Investment Analyst at Gavin Management Group and as a Genetic Counsellor at Mount Sinai Hospital in Toronto.

Gonsalves' background in molecular biology provides her with a unique perspective and expertise in the field of healthcare, which she has leveraged to great success in her career in finance. She has demonstrated her analytical and evaluative skills through her work in equity research, as well as her experience in investment analysis and institutional sales. Gonsalves' deep knowledge of the healthcare industry and her ability to understand complex scientific information sets her apart as a valuable asset to any organization.